Klin Padiatr 2020; 232(02): 95
DOI: 10.1055/s-0040-1701858
PW I-V
Guided Poster Walk
© Georg Thieme Verlag KG Stuttgart · New York

Hodgkin’s disease in children in Moroccan Hospital

S El Moussaoui
1   Faculty of Medicine and Pharmacy, Cadi Ayad University, Marrakech, Morocco
2   Department of Hematology and Pediatric Oncology, Mohammed VI University Hospital, Marrakech, Morocco
,
M Elbaz
1   Faculty of Medicine and Pharmacy, Cadi Ayad University, Marrakech, Morocco
2   Department of Hematology and Pediatric Oncology, Mohammed VI University Hospital, Marrakech, Morocco
,
J Elhoudzi
1   Faculty of Medicine and Pharmacy, Cadi Ayad University, Marrakech, Morocco
2   Department of Hematology and Pediatric Oncology, Mohammed VI University Hospital, Marrakech, Morocco
› Author Affiliations
Further Information

Publication History

Publication Date:
18 March 2020 (online)

Also available at
 
 

    Introduction Hodgkin’s disease is a neoplastic disorder of lymphoid tissue. It remains the first model of malignant tumor curable and curable by combined multidrug therapy and radiotherapy.

    The objective to carry out an epidemiological analysis, to study the clinical and histological aspects, to evaluate the therapeutic response and the evolutive aspects.

    Methods This work is a retrospective study of cases of hodgkin’s disease diagnosed in the department of hematology, pediatric oncology, CHU Mohammed VI Marrakech

    Results As of 2011, 22 cases with Hodgkin’s disease were collected. The mean age is 11.18 with a male predominance of 73%. Cervical adenopathies are affected in 90% of cases. According to the classification of Ann-Arbor stage II is found in 36% of the cases. The scleronodular histologic type is the most frequent (54.5%). All patients are treated according to the MA-MDH 2004 protocol. Complete clinical remission is obtained in 73% of cases. The rate of loss of sight is 18%.

    Conclusion This rate can be reduced by the efforts undertaken in our service by sensitizing patients and their families to adherence to treatment and medical coverage.


    #